Table 1 Demographics and baseline characteristics.
Characteristic | Total (n = 40) | Surgery (n = 21) | Radiotherapy (n = 14) | Withdrewa (n = 5) | |
|---|---|---|---|---|---|
n (%) with gender | male | 35 (87.5) | 19 (90.5) | 12 (85.7) | 4 (80.0) |
Age, median (IQR) | 61 (56, 69) | 58 (52,65) | 69 (59,72) | 64 (57,68) | |
n (%) with smoking status | ever-smoker | 28 (70.0) | 15 (71.4) | 10 (71.4) | 3 (60.0) |
never-smoker | 12 (30.0) | 6 (28.6) | 4 (28.6) | 2 (40.0) | |
n (%) with comorbidity | yes | 22 (55.0) | 10 (47.6) | 10 (71.4) | 2 (20.0) |
n (%) with tumour site | right lung | 22 (55.0) | 11 (52.4) | 7 (50.0) | 4 (80.0) |
left lung | 18 (45.0) | 10 (47.6) | 7 (50.0) | 1 (20.0) | |
n (%) with T | 1 | 3 (7.5) | 2 (9.5) | 1 (7.1) | 0 (0.0) |
2 | 7 (17.5) | 4 (19.0) | 1 (7.1) | 2 (40.0) | |
3 | 7 (17.5) | 2 (9.5) | 4 (28.6) | 1 (20.0) | |
4 | 23 (57.5) | 13 (61.9) | 8 (57.1) | 2 (40.0) | |
n (%) with N | 0 | 2 (5.0) | 1 (4.8) | 1 (7.1) | 0 (0.0) |
1 | 9 (22.5) | 9 (42.9) | 0 (0.0) | 0 (0.0) | |
2 | 21 (52.5) | 7 (33.3) | 9 (64.3) | 5 (100.0) | |
3 | 8 (20.0) | 4 (19.0) | 4 (28.6) | 0 (0.0) | |
n (%) with clinical stage | IB | 1 (2.5) | 1 (4.8) | 0 (0.0) | 0 (0.0) |
IIB | 1 (2.5) | 0 (0.0) | 1 (7.1) | 0 (0.0) | |
IIIA | 16 (40.0) | 12 (57.1) | 2 (14.3) | 2 (40.0) | |
IIIB | 16 (40.0) | 6 (28.6) | 7 (50.0) | 3 (60.0) | |
IIIC | 6 (15.0) | 2 (9.5) | 4 (28.6)b | 0 (0.0) | |
n (%) with site of neoplasm in tracheobronchial | no | 19 (47.5) | 11 (52.4) | 5 (35.7) | 3 (60.0) |
segmental bronchus | 10 (25.0) | 6 (28.6) | 3 (21.4) | 1 (20.0) | |
lobar bronchus | 9 (22.5) | 4 (19.0) | 4 (28.6) | 1 (20.0) | |
left main bronchus | 2 (5.0) | 0 (0.0) | 2 (14.3) | 0 (0.0) | |
n (%) with PD-L1 expression | 0 | 22 (55.0) | 9 (22.5) | 10 (25.0) | 3(7.5) |
\(\ge\)1% | 9 (22.5) | 6 (15.0) | 2 (5.0) | 1 (2.5) | |
NA | 9 (22.5) | 6 (15.0) | 2 (5.0) | 1 (2.5) | |
